Skip to content

Clinical trials

Neoplasm Metastasis trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Brazil Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20045
20052
20064
20073
20085
20094
20105
20113
20125
20134
20145
20154
20163
20174
20181
20196
20203
202112
20228
20232
20245
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Active, not recruiting21
Recruiting18
Terminated9
Unknown status3
Withdrawn3
Not yet recruiting2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca16
Sanofi9
Eli Lilly and Company7
Novartis Pharmaceuticals7
Pfizer6
Institut de Recherches Internationales Servier3
Instituto do Cancer do Estado de São Paulo3
Latin American Cooperative Oncology Group3
Merck Sharp & Dohme LLC3
Regeneron Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis110
Breast Neoplasms26
Neoplasms21
Carcinoma, Non-Small-Cell Lung16
Colorectal Neoplasms12
Lung Neoplasms7
Recurrence7
Pancreatic Neoplasms6
Carcinoma5
Melanoma5

Trials

Showing 51 to 75 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.